Biochemical and clinical characteristics of patients with primary aldosteronism: Single centre experience

• Main Authors: Vujačić Nataša, Paunović Ivan, Diklić Aleksandar, Živaljević Vladan, Slijepčević Nikola, Kalezić Nevena, Stojković Mirjana, Stojanović Miloš, Beleslin Biljana, Žarković Miloš, Ćirić Jasmina
• Format: Article
• Language: English
• Published: Society of Medical Biochemists of Serbia, Belgrade 2020-01-01
• Series: Journal of Medical Biochemistry
• Subjects: primary aldosteronism; biochemical parameters; clinical presentation; adrenal tumour; hypertension; cushing syndrome
• Online Access: https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2020/1452-82582002240V.pdf
• ISSN: 1452-8258; 1452-8266

Background: Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders (impaired glucose and lipid metabolism and insulin resistance), but also with more frequent cardiovascular, renal and central nervous system complications. Methods: Biochemical and clinical parameters were retrospectively analysed for 40 patients with PA caused by aldosterone-producing adenoma (APA) and compared to the control groups of 40 patients with nonfunctioning adrenal adenoma (NFA) and essential hypertension (HT), and 20 patients with adrenal Cushing syndrome (CS) or subclinical CS (SCS). Results: Systolic, diastolic and mean arterial blood pressures were significantly higher in the PA group (p=0.004; p=0.002; p=0.001, respectively) than in NFA+HT group. PA patients had longer hypertension history (p=0.001) than patients with hypercorticism and all had hypokalaemia. This group showed the smallest mean tumour diameter (p<0.001). The metabolic syndrome was significantly less common in the PA group (37.5% vs. 70% in CS+SCS and 65% in NFA+HT group; p=0.015), although there was no significant difference in any of the analysed metabolic parameters between groups. PA group was found to have the most patients with glucose intolerance (81.8%), although the difference was not significant. The mean BMI for all three groups was in the overweight range. Patients with PA had higher microalbuminuria and a higher tendency for cardiovascular, renal and cerebrovascular events, but the difference was not significant. Conclusions: Our results support the importance of the early recognition of primary aldosteronism on the bases of clinical presentation, as well as an increased screening intensity.